This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Sep;56(3):575.

doi: 10.1016/j.eururo.2009.06.020.

Words of wisdom. Re: Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Tran C, Ouk S, Clegg NJ, et al

Henk G van der Poel¹

Affiliations

PMID: 19824150
DOI: 10.1016/j.eururo.2009.06.020

Comment

Words of wisdom. Re: Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Tran C, Ouk S, Clegg NJ, et al

Henk G van der Poel. Eur Urol. 2009 Sep.

. 2009 Sep;56(3):575.

doi: 10.1016/j.eururo.2009.06.020.

Author

Henk G van der Poel¹

Affiliation

¹ Department of Urology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. h.vd.poel@nki.nl

PMID: 19824150
DOI: 10.1016/j.eururo.2009.06.020

No abstract available

PubMed Disclaimer

Comment on

Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL. Tran C, et al. Science. 2009 May 8;324(5928):787-90. doi: 10.1126/science.1168175. Epub 2009 Apr 9. Science. 2009. PMID: 19359544 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science